CN1798558B - 苯并噻唑衍生物和其在制备治疗与腺苷a2a受体有关的疾病的药物中的用途 - Google Patents

苯并噻唑衍生物和其在制备治疗与腺苷a2a受体有关的疾病的药物中的用途 Download PDF

Info

Publication number: CN1798558B
Authority: CN; China
Prior art keywords: morpholin; compound; methyl; hept; methoxy
Prior art date: 2003-05-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CN2004800148906A

Other languages

English (en)

Chinese (zh)

Other versions

CN1798558A (zh

Inventor

A·弗洛尔

R·雅各布-劳特恩

R·D·诺可罗司

C·雷默

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

F Hoffmann La Roche AG

Original Assignee

F Hoffmann La Roche AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-30

Filing date

2004-05-21

Publication date

2012-09-05

2004-05-21 Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG

2006-07-05 Publication of CN1798558A publication Critical patent/CN1798558A/zh

2012-09-05 Application granted granted Critical

2012-09-05 Publication of CN1798558B publication Critical patent/CN1798558B/zh

2024-05-21 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

0 CCN(C)*(C)C(N)=C Chemical compound CCN(C)*(C)C(N)=C 0.000 description 2
DLYIUZJJCDYNHF-UHFFFAOYSA-N COc(c1c2[s]c(NC(I)=O)n1)ccc2N1CCOCC1 Chemical compound COc(c1c2[s]c(NC(I)=O)n1)ccc2N1CCOCC1 DLYIUZJJCDYNHF-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

CN2004800148906A 2003-05-30 2004-05-21 苯并噻唑衍生物和其在制备治疗与腺苷a2a受体有关的疾病的药物中的用途 Expired - Fee Related CN1798558B (zh)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP03012118.0		2003-05-30
EP03012118		2003-05-30
PCT/EP2004/005474 WO2004105755A1 (fr)	2003-05-30	2004-05-21	Derives de benzothiazole et utilisation de ceux-ci dans le traitement des maladies associes au recepteur a2a de l'adenosine

Publications (2)

Publication Number	Publication Date
CN1798558A CN1798558A (zh)	2006-07-05
CN1798558B true CN1798558B (zh)	2012-09-05

Family

ID=33442738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CN2004800148906A Expired - Fee Related CN1798558B (zh)	2003-05-30	2004-05-21	苯并噻唑衍生物和其在制备治疗与腺苷a2a受体有关的疾病的药物中的用途

Country Status (27)

Country	Link
US (1)	US7285548B2 (fr)
EP (1)	EP1633355B1 (fr)
JP (1)	JP4426572B2 (fr)
KR (1)	KR100765566B1 (fr)
CN (1)	CN1798558B (fr)
AR (1)	AR044569A1 (fr)
AT (1)	ATE396726T1 (fr)
AU (1)	AU2004243481B2 (fr)
BR (1)	BRPI0410878A (fr)
CA (1)	CA2527174C (fr)
CL (1)	CL2004001272A1 (fr)
DE (1)	DE602004014138D1 (fr)
DK (1)	DK1633355T3 (fr)
ES (1)	ES2307015T3 (fr)
HR (1)	HRP20080318T3 (fr)
IL (1)	IL171769A (fr)
MX (1)	MXPA05012772A (fr)
MY (1)	MY138018A (fr)
NO (1)	NO20055176L (fr)
NZ (1)	NZ543372A (fr)
PL (1)	PL1633355T3 (fr)
PT (1)	PT1633355E (fr)
RU (1)	RU2348629C2 (fr)
SI (1)	SI1633355T1 (fr)
TW (1)	TW200508230A (fr)
WO (1)	WO2004105755A1 (fr)
ZA (1)	ZA200509608B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2369256T3 (es) *	2000-06-26	2011-11-28	Helen Of Troy Limited	Sistema de lámpara recargable.
CN1989117B (zh) *	2004-07-22	2011-01-19	弗·哈夫曼-拉罗切有限公司	取代的苯并噻唑
US8247609B2 (en) *	2005-10-25	2012-08-21	Pharamleads	Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors
GB0622826D0 (en) *	2006-11-15	2006-12-27	Acurepharma Ab	Novel amides acting on the adenosine receptors
WO2010140339A1 (fr) *	2009-06-01	2010-12-09	武田薬品工業株式会社	Composé hétérocyclique
WO2014096300A2 (fr)	2012-12-21	2014-06-26	Janssen R&D Ireland	Composés antibactériens
DE102019110904B4 (de)	2019-04-26	2022-01-20	Helmholtz-Zentrum Dresden - Rossendorf E. V.	N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001097786A2 (fr) *	2000-06-21	2001-12-27	F. Hoffmann-La Roche Ag	Derives de benzothiazole
WO2003049741A1 (fr) *	2001-12-10	2003-06-19	F. Hoffmann-La Roche Ag	Urees de 2-aminobenzothiazoles servant de modulateurs de l'adenosine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI91859C (fi) *	1987-06-17	1994-08-25	Eisai Co Ltd	Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
IL90337A0 (en) *	1988-05-24	1989-12-15	Pfizer	Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents

2004
- 2004-05-21 RU RU2005141307/04A patent/RU2348629C2/ru not_active IP Right Cessation
- 2004-05-21 BR BRPI0410878-7A patent/BRPI0410878A/pt not_active Application Discontinuation
- 2004-05-21 CA CA2527174A patent/CA2527174C/fr not_active Expired - Fee Related
- 2004-05-21 WO PCT/EP2004/005474 patent/WO2004105755A1/fr not_active Ceased
- 2004-05-21 KR KR1020057022791A patent/KR100765566B1/ko not_active Expired - Fee Related
- 2004-05-21 AT AT04734217T patent/ATE396726T1/de active
- 2004-05-21 NZ NZ543372A patent/NZ543372A/en unknown
- 2004-05-21 MX MXPA05012772A patent/MXPA05012772A/es active IP Right Grant
- 2004-05-21 EP EP04734217A patent/EP1633355B1/fr not_active Expired - Lifetime
- 2004-05-21 DK DK04734217T patent/DK1633355T3/da active
- 2004-05-21 JP JP2006508188A patent/JP4426572B2/ja not_active Expired - Fee Related
- 2004-05-21 AU AU2004243481A patent/AU2004243481B2/en not_active Ceased
- 2004-05-21 SI SI200430752T patent/SI1633355T1/sl unknown
- 2004-05-21 PT PT04734217T patent/PT1633355E/pt unknown
- 2004-05-21 HR HR20080318T patent/HRP20080318T3/xx unknown
- 2004-05-21 ES ES04734217T patent/ES2307015T3/es not_active Expired - Lifetime
- 2004-05-21 DE DE602004014138T patent/DE602004014138D1/de not_active Expired - Lifetime
- 2004-05-21 CN CN2004800148906A patent/CN1798558B/zh not_active Expired - Fee Related
- 2004-05-21 PL PL04734217T patent/PL1633355T3/pl unknown
- 2004-05-26 CL CL200401272A patent/CL2004001272A1/es unknown
- 2004-05-26 TW TW093114971A patent/TW200508230A/zh unknown
- 2004-05-26 US US10/854,059 patent/US7285548B2/en not_active Expired - Fee Related
- 2004-05-27 MY MYPI20042036A patent/MY138018A/en unknown
- 2004-05-28 AR ARP040101840A patent/AR044569A1/es not_active Application Discontinuation
2005
- 2005-11-03 NO NO20055176A patent/NO20055176L/no unknown
- 2005-11-03 IL IL171769A patent/IL171769A/en active IP Right Grant
- 2005-11-28 ZA ZA200509608A patent/ZA200509608B/en unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001097786A2 (fr) *	2000-06-21	2001-12-27	F. Hoffmann-La Roche Ag	Derives de benzothiazole
WO2003049741A1 (fr) *	2001-12-10	2003-06-19	F. Hoffmann-La Roche Ag	Urees de 2-aminobenzothiazoles servant de modulateurs de l'adenosine
CN1602196A (zh) *	2001-12-10	2005-03-30	弗·哈夫曼-拉罗切有限公司	作为腺苷调节剂的2－氨基苯并噻唑脲

Also Published As

Publication number	Publication date
KR20060032955A (ko)	2006-04-18
RU2348629C2 (ru)	2009-03-10
US7285548B2 (en)	2007-10-23
HRP20080318T3 (en)	2008-07-31
EP1633355A1 (fr)	2006-03-15
WO2004105755A1 (fr)	2004-12-09
CN1798558A (zh)	2006-07-05
AU2004243481B2 (en)	2008-10-09
PL1633355T3 (pl)	2008-10-31
MY138018A (en)	2009-04-30
NO20055176L (no)	2005-11-03
JP4426572B2 (ja)	2010-03-03
JP2006526003A (ja)	2006-11-16
ZA200509608B (en)	2007-04-25
AU2004243481A1 (en)	2004-12-09
US20040242576A1 (en)	2004-12-02
MXPA05012772A (es)	2006-02-13
EP1633355B1 (fr)	2008-05-28
NZ543372A (en)	2008-11-28
SI1633355T1 (sl)	2008-08-31
AR044569A1 (es)	2005-09-21
KR100765566B1 (ko)	2007-10-09
ES2307015T3 (es)	2008-11-16
TW200508230A (en)	2005-03-01
CA2527174C (fr)	2014-03-25
RU2005141307A (ru)	2006-07-27
BRPI0410878A (pt)	2006-07-04
PT1633355E (pt)	2008-07-15
IL171769A (en)	2010-12-30
ATE396726T1 (de)	2008-06-15
CA2527174A1 (fr)	2004-12-09
CL2004001272A1 (es)	2005-04-22
DK1633355T3 (da)	2008-08-04
DE602004014138D1 (de)	2008-07-10

Legal Events

Date	Code	Title	Description
2006-07-05	C06	Publication
2006-07-05	PB01	Publication
2006-08-30	C10	Entry into substantive examination
2006-08-30	SE01	Entry into force of request for substantive examination
2007-02-23	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1093021 Country of ref document: HK
2012-09-05	C14	Grant of patent or utility model
2012-09-05	GR01	Patent grant
2012-12-28	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1093021 Country of ref document: HK
2020-05-15	CF01	Termination of patent right due to non-payment of annual fee	Granted publication date: 20120905 Termination date: 20190521
2020-05-15	CF01	Termination of patent right due to non-payment of annual fee

Publication	Publication Date	Title
EP1455792B1 (fr)	2007-04-18	Urees de 2-aminobenzothiazoles servant de modulateurs de l'adenosine
US6599901B1 (en)	2003-07-29	Pyridone substituted benzothiazole derivatives
CN1956983B (zh)	2010-05-26	4-羟基-4-甲基-哌啶-1-甲酸(4-甲氧基-7-吗啉-4-基-苯并噻唑-2-基)-酰胺
EP1773827B1 (fr)	2010-02-17	Derives de benzothiazole
CN1798558B (zh)	2012-09-05	苯并噻唑衍生物和其在制备治疗与腺苷a2a受体有关的疾病的药物中的用途
EP1450797B1 (fr)	2006-06-21	Derives de benzothiazole
CN1989117B (zh)	2011-01-19	取代的苯并噻唑
EP1456196B1 (fr)	2009-01-07	Benzothiophenes en tant que modulateurs du recepteur de l'adenosine